The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance

Japanese Journal of Psychopharmacology

Volumn 20, Issue 3, 2000, Pages 123-130

  Uchiumi, M ^a   Isawa, S ^a   Suzuki, M ^a   Murasaki, M ^a  

^a Asuka Hospital   (Japan)

Author keywords

Daytime sleepiness; Double blind cross over study; Psychomotor performance; Zolpidem; Zopiclone

Indexed keywords

RECEPTOR SUBTYPE; ZOLPIDEM; ZOPICLONE;

ADULT; ANALYTIC METHOD; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECEPTOR AFFINITY; SOMNOLENCE; TASK PERFORMANCE;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; PYRIDINES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0033671411     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics
2. 3H] Ro 15-1788) in the mouse brain: Preferential affinity of zolpidem for the omega 1(BZD1) subtype
3. The use of analogue scales in rating subjective feelings
4. Effect of total sleep loss on sleep tendency
5. Multiple sleep latency test during the constant routine
6. Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness
7. Issues in the diagnosis and treatment of insomnia
8. 3H] zolpidem
9. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects
10. Effet du zolpidem et de ses metabolites sur l'electrocorticogramme chez le rat
11. Pharmacokinetics and metabolism of zopiclone
12. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency
13. Zopiclone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic
14. Quantification of sleepiness: A new approach
15. Standardization in platform stabilometry being a part of posturography
16. Clinical evaluation of zolpidem on insomnia in neuropsychiatric field: Dose-finding study on insomnia of patients with schizophrenia and manic-depressive psychosis
17. Phase 1 study of zolpidem: Single and multiple dose studies
18. Optimal dose finding study of zolpidem, an imidazopyridine hypnotic, by the double-blind technique
19. Receptors involved in the mechanism of action of zolpidem
20. 3H] flunitrazepam binding sites
21. Differences in pharmacological profile of a new generation of benzodiazepine and non-benzodiazepine hypnotics
22. Level of sleepiness and total sleep time following various time in bed condition
23. Pharmacokinetics and metabolism of zolpidem in various animal species and in humans
24. Clinical evaluation of zolpidem, a new hypnotic, in the fields of internal medicine and psychosomatic medicine
25. Effects of a single dose of zolpidem, triazolam and nitrazepam on daytime sleepiness
26. Abuse liability of benzodiazepines